Effects of PH3 in Diabetic Nephropathy
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.
Also called NCT01068041
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase
- Phase 2
- Enrolled
- 100 participants
- Sponsor
- PhytoHealth Corporation
- Registry
-
NCT01068041
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Taiwan
- Registry status
- Completed
Technical summary
Registry record NCT01068041. Randomized; quadruple masking; primary purpose prevention. Start 2010-08 (registry gives no type); primary completion 2014-07 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effects of PH3 in Diabetic Nephropathy
- Acronym
- PH3
- Condition
- Diabetic Nephropathy
- Intervention (Drug)
- PH3
- Lead sponsor
- PhytoHealth Corporation
Record details
- Record id
cardio:ct-nct01068041- Content hash
555433446c7eb9c425d88aef571af13fff8492c82dabc91f3f814ef138e90a7a